ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Joyuus LLC Receives $1.7 Million in Small Business Innovative Research Grant Funding to Develop Postpartum Technology Program

Bringing together a powerful team of experts, Joyuus tackles the intractable problem of the lack of adequate accessible, postpartum care.

Joyuus™, LLC, a digital health startup in women's health, today announced it received $1.7 million in Phase II Small Business Innovative Research (SBIR) grant funding through the National Institutes of Health, National Institute on Minority Health, and Health Disparities.

Of the 4 million births per year, one in three women will have a severe (often preventable) health outcome. Black and brown women are 3-4 times more likely to die from preventable postpartum complications than white women. One in seven women suffers from depression over the 12 months after having a baby. Too many women struggle unnecessarily. Founded by experts in health research, product development, and design, Joyuus is working on converting scientific research into an impactful healthcare solution.

Through this funding, Joyuus will deliver evidence-based information on over 100 topics impacting moms during the entire 12 months after having a baby, from acute clinical concerns to physical, mental, and real-life issues to give women power over their postpartum health.

"The challenges related to lack of postpartum care have improved little in two decades," says, Co-founder Lisa Marceau who experienced undiagnosed postpartum depression firsthand 19 years ago after having her first child. "Joyuus is a digital health technology innovator bringing accessible postpartum self-care to women where they are in their postpartum journey."

Joyuus founders Lisa Marceau and Kristine Merz bring 30 years of expertise in human-centered research and design. They are joined by clinical expert and Co-Investigator Dr. Allison Bryant (Massachusetts General Hospital) and a team of developers, clinical experts, designers, and content experts, and supported by accelerators and tech giants such as Alpha3 Cloud, Hewlett Packard Enterprise, Leafpoint, New England Medical Innovation Center (NEMIC), Social Enterprise Greenhouse and RIHub Venture Mentoring Service.

Research reported in this release was supported by National Institute on Minority Health and Health Disparities of the National Institutes of Health under grant R44MD014923. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

~~

Joyuus, LLC is a digital health innovator dedicated to creating accessible well-being for moms and those who care about them during the 12 months postpartum. We do this by valuing people's insights in everything we do. Our digital health platform empowers all those who have had a baby to make informed decisions in their 12-month journey. Joyuus provides real-time, evidence-based, actionable health information and resources tailored to each user across physical, mental, and real-life concerns. This approach helps to identify when earlier access to treatment may be necessary to avoid serious postpartum complications.

Contact Information:
Lisa Marceau
Co-Founder
info@joyuus.com


Original Source: Joyuus LLC Receives $1.7 Million in Small Business Innovative Research Grant Funding to Develop Postpartum Technology Program
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.